STAT Plus: Biotech IPOs are soaring. This one will test investors’ appetite for risk

Biotech companies are getting creative in illustrating their pipelines.

More From BioPortfolio on "STAT Plus: Biotech IPOs are soaring. This one will test investors’ appetite for risk"